home / stock / pki / pki news


PKI News and Press, PerkinElmer Inc. From 07/26/21

Stock Information

Company Name: PerkinElmer Inc.
Stock Symbol: PKI
Market: NYSE
Website: perkinelmer.com

Menu

PKI PKI Quote PKI Short PKI News PKI Articles PKI Message Board
Get PKI Alerts

News, Short Squeeze, Breakout and More Instantly...

PKI - Shares of PerkinElmer Inc. (PKI) Have Risen Above Previous 52-Week High

PerkinElmer Inc. (NYSE:PKI) traded today at a new 52-week high of $169.11. This new high was reached on approximately average trading volume as 499,000 shares traded hands, while the average 30-day volume is approximately 664,000 shares. PerkinElmer provides instruments, tests, services,...

PKI - PerkinElmer to acquire BioLegend for ~$5.25 billion in cash and stock

Atstock Productions/iStock via Getty Images Privately-held BioLegend is a provider of antibodies and reagents in areas such as cytometry, proteogenomics, multiplex assays, recombinant proteins, magnetic cell separation, and bioprocessing. BioLegend has over 700 employees based in the U.S., wi...

PKI - PerkinElmer EPS beats by $0.39, beats on revenue; Initiates 3Q guidance and raises full year guidance

PerkinElmer (PKI): Q2 Non-GAAP EPS of $2.83 beats by $0.39; GAAP EPS of $2.19 beats by $0.19.Revenue of $1.23B (+51.5% Y/Y) beats by $110M.For the third quarter of 2021, the Company forecasts adjusted revenue of ~$1.00B vs. consensus of $969.34M and adjusted earnings per share of $1.62 v...

PKI - PerkinElmer Announces Financial Results for the Second Quarter of 2021

Revenue of $1.228 billion; 51% reported growth; 41% organic growth GAAP EPS from continuing operations of $2.19; Adjusted EPS of $2.83 Initiates Third Quarter and Raises Full-Year Revenue and Earnings Guidance Announces Agreement to Acquire BioLegend –...

PKI - PerkinElmer to Acquire Antibody and Reagent Leader BioLegend

Transformative deal significantly scales leading position in life science to accelerate legendary discoveries in precision medicine Leader in antibody development with highly complementary, innovative portfolio in emerging, high-growth areas of biologics, cell and gene t...

PKI - Perkinelmer PKI Trading Advice

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

PKI - PerkinElmer Inc.: The Winning Streak Continues (PKI)

Shares of PerkinElmer Inc. (NYSE:PKI) traded today at $163.99, eclipsing its 52-week high. This new high was reached on below average trading volume as 235,000 shares traded hands, while the average 30-day volume is approximately 653,000 shares. Over the past year, PerkinElmer Inc. has t...

PKI - IDNA And Healthcare Dashboard For July

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IDNA. A list of cheap stocks. For further details see: IDNA And Healthcare Dashboard For July

PKI - When Perkinelmer (PKI) Moves Investors should Listen

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

PKI - Perkinelmer PKI Technical Data

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Previous 10 Next 10